Venture-capital backed Domain Therapeutics SA of France has received a grant from the Michael J. Fox Foundation to develop allosteric modulators for Parkinson’s disease. This follows a year-earlier licensing deal with Merck Serono, also for PD. ---Subscribe to MedNous to access this article--- Finance, Grants, Deals Company News
